{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:20:30Z","timestamp":1789633230919,"version":"build-2803163510"},"reference-count":37,"publisher":"Galenos Yayinevi","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjo"],"published-print":{"date-parts":[[2022,6,29]]},"DOI":"10.4274\/tjo.galenos.2021.66168","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T08:12:08Z","timestamp":1652775128000},"page":"157-161","source":"Crossref","is-referenced-by-count":10,"title":["Dry Eye and Meibomian Gland Dysfunction in Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Injections"],"prefix":"10.4274","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3581-7059","authenticated-orcid":false,"given":"Pelin","family":"K\u0131yat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-0131","authenticated-orcid":false,"given":"Melis","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-9492","authenticated-orcid":false,"given":"Serhad","family":"Nal\u00e7ac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7048-9599","authenticated-orcid":false,"given":"Cezmi","family":"Akk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"DS","year":"2004","unstructured":"1. Friedman DS, O'Colmain BJ, Mu\u00f1oz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.","journal-title":"Arch Ophthalmol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1001\/archopht.116.5.653","article-title":"Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam study","volume":"116","author":"Klaver","year":"1998","unstructured":"2. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam study. Arch Ophthalmol. 1998;116:653-658.","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/15569527.2017.1291665","article-title":"Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections","volume":"36","author":"Saedon","year":"2017","unstructured":"3. Saedon H, Nosek J, Phillips J, Narendran N, Yang YC. Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections. Cutan Ocul Toxicol. 2017;36:343-346.","journal-title":"Cutan Ocul Toxicol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1097\/IAE.0000000000001800","article-title":"Pain and antisepsis after ocular administration of povidone-iodine versus chlorhexidine","volume":"38","author":"Oakley","year":"2018","unstructured":"4. Oakley C, Allen P, Hooshmand J, Vote BJT. Pain and antisepsis after ocular administration of povidone-iodine versus chlorhexidine. Retina. 2018;38: 2064-2066.","journal-title":"Retina"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"JS","year":"2012","unstructured":"5. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U; VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119:2537-2548.","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","article-title":"The use of povidone-iodine in ophthalmology","volume":"29","author":"Grzybowski","year":"2018","unstructured":"6. Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2018;29:19-32.","journal-title":"Curr Opin Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ajo.2013.10.003","article-title":"Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics","volume":"157","author":"Hsu","year":"2014","unstructured":"7. Hsu J, Gerstenblith AT, Garg SJ, Vander JF. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014;157:514-518.","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","unstructured":"8. Periman LM, Perez VL, Saban DR, Lin MC, Neri P. The immunological basis of dry eye disease and current topical treatment options. J Ocul Pharmacol Ther. 2020;36:137-146.","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","unstructured":"9. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, Viso E, Vitale S, Jones L. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15:334-365.","journal-title":"Ocul Surf"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson","year":"2011","unstructured":"10. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930-1937.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","unstructured":"11. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276-283.","journal-title":"Ocul Surf"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on Meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the Meibomian gland","volume":"52","author":"Knop","year":"2011","unstructured":"12. Knop E, Knop N, Millar T, Obata H, Sullivan D. The international workshop on Meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the Meibomian gland. Invest Ophthalmol Vis Sci. 2011;52:1938-1978.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/diagnostics10060404","article-title":"Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity","volume":"10","author":"Gagliano","year":"2020","unstructured":"13. Gagliano C, Visalli E, Toro MD, Amato R, Panta G, Scollo D, Scandura G, Ficili S, Amato G, Benenati A, Foti R, Malaguarnera G, Gagliano G, Falsaperla R, Avitabile T, Foti R. Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity. Diagnostics (Basel). 2020;10:404.","journal-title":"Diagnostics (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/ICO.0000000000002356","article-title":"Dry eye and quantitative and qualitative changes of Meibomian glands in patients with pemphigus","volume":"39","author":"Kiyat","year":"2020","unstructured":"14. Kiyat P, Palamar M, Gerceker Turk B, Yagci A. Dry eye and quantitative and qualitative changes of Meibomian glands in patients with pemphigus. Cornea. 2020;39:1108-1111.","journal-title":"Cornea"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/ICO.0000000000002551","article-title":"Evaluation of Ocular Surface and Meibomian Glands in Patients With Scleroderma","volume":"40","author":"Adiguzel","year":"2021","unstructured":"15. Adiguzel S, Palamar M, Yargucu F, Oksel F, Yagci A. Evaluation of Ocular Surface and Meibomian Glands in Patients With Scleroderma. Cornea. 2021;40:977-981.","journal-title":"Cornea"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","article-title":"Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population","volume":"115","author":"Arita","year":"2008","unstructured":"16. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115:911-915.","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/09273941003721926","article-title":"Dry eye disease as an inflammatory disorder","volume":"18","author":"Calonge","year":"2010","unstructured":"17. Calonge M, Enr\u00edquez-de-Salamanca A, Diebold Y, Gonz\u00e1lez-Garc\u00eda MJ, Reinoso R, Herreras JM, Corell A. Dry eye disease as an inflammatory disorder. Ocul Immunol Inflamm. 2010;18:244-253.","journal-title":"Ocul Immunol Inflamm"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1167\/iovs.02-0581","article-title":"Apoptosis of ocular surface cells in experimentally induced dry eye","volume":"44","author":"Yeh","year":"2003","unstructured":"18. Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci. 2003;44:124-129.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","article-title":"Important causes of visual impairment in the world today","volume":"290","author":"Congdon","year":"2003","unstructured":"19. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290:2057-2060.","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","unstructured":"20. Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina. 2006;26:859-870.","journal-title":"Retina"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"MG","year":"1991","unstructured":"21. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769-1775.","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/15569520903080511","article-title":"The toxic effect of different concentrations of povidone iodine on the rabbit's cornea","volume":"28","author":"Jiang","year":"2009","unstructured":"22. Jiang J, Wu M, Shen T. The toxic effect of different concentrations of povidone iodine on the rabbit's cornea. Cutan Ocul Toxicol. 2009;28:119-124.","journal-title":"Cutan Ocul Toxicol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2147\/OPTH.S136500","article-title":"The effect of intravitreal injections on dry eye, and proposed management strategies","volume":"11","author":"Laude","year":"2017","unstructured":"23. Laude A, Lim JW, Srinagesh V, Tong L. The effect of intravitreal injections on dry eye, and proposed management strategies. Clin Ophthalmol. 2017;11:1491-1497.","journal-title":"Clin Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/ICU.0000000000000326","article-title":"Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection","volume":"28","author":"Garg","year":"2017","unstructured":"24. Garg P, Roy A, Sharma S. Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol. 2017;28:67-72.","journal-title":"Curr Opin Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/ACI.0b013e32834a95c9","article-title":"Ocular surface damage by ophthalmic compounds","volume":"11","author":"Mantelli","year":"2011","unstructured":"25. Mantelli F, Tranchina L, Lambiase A, Bonini S. Ocular surface damage by ophthalmic compounds. Curr Opin Allergy Clin Immunol. 2011;11:464-470.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jcjo.2011.09.017","article-title":"In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes","volume":"46","author":"Mencucci","year":"2011","unstructured":"26. Mencucci R, Paladini I, Pellegrini-Giampietro DE, Menchini U, Scartabelli T. In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes. Can J Ophthalmol. 2011;46:513-520.","journal-title":"Can J Ophthalmol"},{"key":"ref26","unstructured":"27. Li XM, Zhao X, Hu LZ, Wang W. [Clinical observation of dry eye in patients before and after cataract surgery]. Zhonghua Yan Ke Za Zhi. 2007;43:10-13."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000308974","article-title":"Morphological changes of the corneal epithelium after application of topical anaesthetic ointments","volume":"180","author":"Brewitt","year":"1980","unstructured":"28. Brewitt H, Bonatz E,Honegger H. Morphological changes of the corneal epithelium after application of topical anaesthetic ointments. Ophthalmologica. 1980;180:198-206.","journal-title":"Ophthalmologica"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/aos.14797","article-title":"A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study","volume":"99","author":"Verrecchia","year":"2021","unstructured":"29. Verrecchia S, Chiambaretta F, Kodjikian L, Nakouri Y, El Chehab H, Mathis T, Badri Y, Chudzinski R, Levron A, Chaperon M, Agard E, Pradat P, Dot C. A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study. Acta Ophthalmol. 2021;99:877-884.","journal-title":"Acta Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1096\/fj.12-225185","article-title":"Vascular endothelial growth factor promotes anatomical and functional recovery of injured peripheral nerves in the avascular cornea","volume":"27","author":"Pan","year":"2013","unstructured":"30. Pan Z, Fukuoka S, Karagianni N, Guaiquil VH, Rosenblatt MI. Vascular endothelial growth factor promotes anatomical and functional recovery of injured peripheral nerves in the avascular cornea. FASEB J. 2013;27:2756-2767.","journal-title":"FASEB J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40942-021-00307-7","article-title":"Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review","volume":"7","author":"Anderson","year":"2021","unstructured":"31. Anderson WJ, da Cruz NFS, Lima LH, Emerson GG, Rodrigues EB, Melo GB. Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review. Int J Retina Vitreous. 2021;7:37.","journal-title":"Int J Retina Vitreous"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/jcm10050981","article-title":"Inflammatory complications of intravitreal anti-VEGF injections","volume":"10","author":"Cox","year":"2021","unstructured":"32. Cox JT, Eliott D, Sobrin L. Inflammatory complications of intravitreal anti-VEGF injections. J Clin Med. 2021;10:981.","journal-title":"J Clin Med"},{"key":"ref32","unstructured":"33. Karti O, Ipek SC, Ates Y, Saatci AO. Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place of Intravitreal Anti-VEGF Therapy. Med Hypothesis Discov Innov Ophthalmol. 2020;9:118-126."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/ICO.0000000000000393","article-title":"Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea","volume":"34","author":"Palamar","year":"2015","unstructured":"34. Palamar M, Degirmenci C, Ertam I, Yagci A. Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea. Cornea. 2015;34:497-499.","journal-title":"Cornea"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/eye.2017.38","article-title":"Evaluation of dry eye and meibomian gland dysfunction with meibography in vitiligo","volume":"31","author":"Palamar","year":"2017","unstructured":"35. Palamar M, Kiyat P, Ertam I, Yagci A. Evaluation of dry eye and meibomian gland dysfunction with meibography in vitiligo. Eye (Lond). 2017;31:1074-1077.","journal-title":"Eye (Lond)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10792-018-0824-3","article-title":"Dry eye and meibomian gland dysfunction in pseudophakic bullous keratopathy","volume":"39","author":"Palamar","year":"2019","unstructured":"36. Palamar M, Kiyat P, Yagci A. Dry eye and meibomian gland dysfunction in pseudophakic bullous keratopathy. Int Ophthalmol. 2019;39:393-396.","journal-title":"Int Ophthalmol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/ICL.0000000000000351","article-title":"Meibomian gland dysfunction and contact lens discomfort","volume":"43","author":"Arita","year":"2017","unstructured":"37. Arita R, Fukuoka S, Morishige N. Meibomian gland dysfunction and contact lens discomfort. Eye Contact Lens. 2017;43:17-22.","journal-title":"Eye Contact Lens"}],"container-title":["Turkish Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T09:02:30Z","timestamp":1721984550000},"score":1,"resource":{"primary":{"URL":"https:\/\/oftalmoloji.org\/articles\/doi\/tjo.galenos.2021.66168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,6,29]]},"published-print":{"date-parts":[[2022,6,29]]}},"URL":"https:\/\/doi.org\/10.4274\/tjo.galenos.2021.66168","relation":{},"ISSN":["1300-0659","2147-2661"],"issn-type":[{"value":"1300-0659","type":"print"},{"value":"2147-2661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}